Drug intelligence / Profile preview

femicept

Development stage
Unknown
Lead developer
Viatris
Modality
Small Molecules
Administration
Oral
01

Overview

Femicept is a combined oral contraceptive tablet containing two active ingredients: levonorgestrel (150 micrograms) and ethinylestradiol (30 micrograms)[2][8]. It belongs to the class of estrogen-progestogen combination contraceptives, commonly referred to as "the Pill." The primary mechanism of action is inhibition of ovulation via suppression of the hypothalamo-pituitary–ovarian axis, specifically preventing the mid-cycle surge in luteinising hormone. Additional contraceptive effects include thickening cervical mucus to impede sperm penetration and altering the endometrium to reduce receptivity for implantation[2]. Femicept is indicated for pregnancy prevention. Its efficacy and safety are supported by bioequivalence studies comparing it with established reference products such as Microgynon 30[2].

Brand names
Femicept
Other names
Levest 150/30Microgynon 30 (reference product)
02

Targets

PR (Progesterone receptor)ER (Estrogen receptor)

Beyond the preview

Go deeper on femicept.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on femicept.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call